Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.

Parato KG, Kumar A, Badley AD, Sanchez-Dardon JL, Chambers KA, Young CD, Lim WT, Kravcik S, Cameron DW, Angel JB.

AIDS. 2002 Jun 14;16(9):1251-6.

PMID:
12045490
3.

Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10.

Cervenak L, Morbidelli L, Donati D, Donnini S, Kambayashi T, Wilson JL, Axelson H, Castaños-Velez E, Ljunggren HG, Malefyt RD, Granger HJ, Ziche M, Bejarano MT.

Blood. 2000 Oct 1;96(7):2568-73.

5.

Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer.

Kim KN, Watanabe S, Ma Y, Thornton S, Giannini EH, Hirsch R.

J Immunol. 2000 Feb 1;164(3):1576-81.

6.

IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18.

Cai G, Kastelein RA, Hunter CA.

Eur J Immunol. 1999 Sep;29(9):2658-65.

PMID:
10508240
7.

UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses.

Garssen J, Vandebriel RJ, De Gruijl FR, Wolvers DA, Van Dijk M, Fluitman A, Van Loveren H.

Immunology. 1999 Jul;97(3):506-14.

8.

Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer.

Ma Y, Thornton S, Duwel LE, Boivin GP, Giannini EH, Leiden JM, Bluestone JA, Hirsch R.

J Immunol. 1998 Aug 1;161(3):1516-24.

9.
10.
11.

Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice.

Beissert S, Hosoi J, Kühn R, Rajewsky K, Müller W, Granstein RD.

J Invest Dermatol. 1996 Oct;107(4):553-7.

12.

Functional CD86 (B7-2/B70) on cultured human Langerhans cells.

Yokozeki H, Katayama I, Ohki O, Matsunaga T, Watanabe K, Satoh T, Azuma M, Okumura K, Nishioka K.

J Invest Dermatol. 1996 Jan;106(1):147-53.

13.

Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S.

J Immunol. 1993 Jan 15;150(2):353-60.

PMID:
8419468
14.

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.

Powrie F, Menon S, Coffman RL.

Eur J Immunol. 1993 Nov;23(11):3043-9.

PMID:
8223881
15.

Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells.

Péguet-Navarro J, Moulon C, Caux C, Dalbiez-Gauthier C, Banchereau J, Schmitt D.

Eur J Immunol. 1994 Apr;24(4):884-91.

PMID:
8149959
16.

Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.

Enk AH, Angeloni VL, Udey MC, Katz SI.

J Immunol. 1993 Sep 1;151(5):2390-8.

PMID:
8103065
17.

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.

Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG.

J Exp Med. 1993 Jun 1;177(6):1797-802.

18.

IL-12: initiation cytokine for cell-mediated immunity.

Scott P.

Science. 1993 Apr 23;260(5107):496-7. Review. No abstract available.

PMID:
8097337
19.

Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production.

Macatonia SE, Doherty TM, Knight SC, O'Garra A.

J Immunol. 1993 May 1;150(9):3755-65.

PMID:
8097224
20.

In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions.

Schwarz A, Grabbe S, Riemann H, Aragane Y, Simon M, Manon S, Andrade S, Luger TA, Zlotnik A, Schwarz T.

J Invest Dermatol. 1994 Aug;103(2):211-6.

Supplemental Content

Support Center